Fibrotic tissues create a stiffened extracellular matrix that can facilitate the invasion and migration of cancer cells. This process is known as the epithelial-mesenchymal transition (EMT), where cancer cells gain migratory and invasive characteristics. Furthermore, fibrosis can limit the effectiveness of anti-cancer treatments by creating physical barriers that prevent the delivery of therapeutic agents to the tumor cells.
